Globus Medical, Inc. (GMED) Profit Margin
Globus Medical, Inc. (GMED) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2016-12-31 | 18.50% |
| 2017-12-31 | 16.88% |
| 2018-12-31 | 95.49% |
| 2019-12-31 | 19.76% |
| 2020-12-31 | 12.96% |
| 2021-12-31 | 15.57% |
| 2022-12-31 | 18.59% |
| 2023-12-31 | 7.83% |
| 2024-12-31 | 4.09% |
| 2025-12-31 | 18.30% |
How GMED compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| AMGN | Amgen Inc. | 20.98% |
| ILMN | Illumina Inc. | 19.57% |
| A | Agilent Technologies Inc. | 18.75% |
| TMO | Thermo Fisher Scientific Inc | 15.05% |
| DHR | Danaher Corporation | 14.71% |
These are five companies in the same sector as GMED with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Globus Medical, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("GMED", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | GMED | $85.94 | +0.32% | 1.39M |
| 3 | ||||
| 4 | ||||
| 5 |